| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
-
|
-
|
1
|
21,911
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
-
|
-
|
1
|
21,911
| |
|
Operating Expenses |
|
Research Development | 20,231 | 40,017 | 21,495 | 28,532 |
|
Selling General and Administrative | 7,430 | 7,111 | (40,261) | 7,665 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(27,661)
|
(47,128)
|
18,767
|
(14,286)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 335 | 143 | 169 | 320 |
|
Earnings Before Interest And Taxes | (27,326) | (46,985) | 18,936 | (13,966) |
|
Interest Expense |
-
|
-
| 533 | 694 |
|
Income Before Tax | (27,326) | (46,985) | 18,403 | (14,660) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (27,326) | (46,985) | 18,403 | (14,660) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(27,326)
|
(46,985)
|
18,403
|
(14,660)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(27,326)
|
(46,985)
|
18,403
|
(14,660)
|
|
0.47(1.84%) 12:12PM EDT - Nasdaq Real Time Price